Last week, news started circulating that the head transplant operation spearheaded by controversial Italian professor named Sergio Canavero was a success. Publications quickly picked the story up and spread the word, but the larger medical and scientific community are intent on putting the brakes on it. According to practically every credible science organization, institution, and journal, a head transplant is simply impossible with current medical technology.
The flurry of headlines and tacky puns started when The Telegraph published an interview with Canavero who claimed that a team of doctors was able to successfully perform a head transplant on a corpse. The operation was done in China, with Dr. Xiaoping Ren of Harbin Medical University leading the team.
After more than 18 hours, the operation was apparently a success, with nerves, blood vessels, and the spine of two people being attached. This is a medical breakthrough that the industry could only dream of and for many professionals in the field, it remains a dream.
One of the people who is skeptical of Canavero’s claim, to say the least, is Arthur Caplan. The NYU School of Medicine medical ethics head, Caplan told Futurism that what the controversial figure said is absolutely impossible. Transplanting a face is hard enough as it is, but doing it with an entire human head is borderline science fiction.
“The way he talks about head transplants, it’s like unscrewing a bulb from a socket and putting in a new one,” Caplan said. “But obviously the chemistry where the new brain will be exposed, and the neural inputs, will be very different. Even if you could keep somebody alive – which I doubt, because of immune rejection – but even if you could, I think they’d be insane, because the brain wouldn’t be able to process the new environment. I think that’s a limit on head transplants, generally.”
Caplan’s views mirror that of many other neurologists, neurosurgeons, and practically the entire global medical community. This isn’t to say that a head transplant will never be performed. It just can’t be done right now or in the near future.


Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump Administration Releases New UFO Files and Apollo Mission Records
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 



